Med-Scribe Inc Fairport, NY - 14450

Med-Scribe Inc is categorized under Employment Agencies and Opportunities in Fairport, NY and active since 1987.

Med-Scribe Inc was established in 1987, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Employment Agencies and Opportunities business, which does work in the B2B market, and is classified as a Employment Agencies and Opportunities, under code number 5613110 by the NAICS.

If you are seeking more information, feel free to contact Bobbie Rief, Owner at the company’s single location by writing to 535 Willowbrook Office Park, Fairport, New York NY 14450 or by phoning (585) 586-0790. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Med-Scribe Inc
Contact Person: Bobbie Rief, Owner
Address: 535 Willowbrook Office Park, Fairport, New York 14450
Phone Number: (585) 586-0790
Website Address: medscribe.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 1987
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Employment Agencies and Opportunities
SIC Code: 7361
NAICS Code: 5613110
Share This Business:

Med-Scribe Inc was started in 1987 to provide professional Employment Agencies and Opportunities under the SIC code 7361 and NAICS code 5613110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Bobbie Rief, Owner for inquiries that concern Med-Scribe Inc by calling the company number (585) 586-0790, as your correspondence is most welcome. Additionally, the physical location of the single location of Med-Scribe Inc can be found at the coordinates 43.03626,-77.45615 as well as the street address 535 Willowbrook Office Park in Fairport, New York 14450.

For its online presence, you may visit Med-Scribe Inc’s website at medscribe.com and engage with its social media outlets through on Twitter and on Facebook.